Description
Pharmacovigilance China 2011 deals with harmanised pharmacovigilance framework, ADR case evaluation, post-market, clinical stage pharmacovigilance, drug safety in China, clinical trials and marketing.
The event brings together pharmacovigliance regulators and industry practitioners.